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Background: Transbronchial lung biopsy using a cryoprobe is a novel way of sampling 
lung parenchyma. Correlation of freezing time with biopsy size and complications has 
not been evaluated in vivo. Objectives: The primary aim of the study is to evaluate the 
correlation between transbronchial cryobiopsy freezing time and size. The secondary 
aims are to evaluate histological quality of the biopsy and evaluate procedure-associated 
complications. Methods: Transbronchial lung cryobiopsies were obtained from two 
anaesthetised sheep using a 1.9-mm cryoprobe inserted into a flexible bronchoscope 
under fluoroscopic guidance. Freezing times ranged from 1 to 6 s (n = 49). The 
cryobiopsies were evaluated histologically with respect to their size and quality. 
Complications of bleeding and pneumothorax were recorded. Results: The mean cross-
sectional area of the cryobiopsy ranged from 4.7 ± 2.1 to 15.7 ± 15.3 mm2. There was a 
significant positive correlation between increasing freezing time and cryobiopsy cross-
sectional area (p = 0.028). All biopsies contained lung tissue with preserved 
parenchyma. Crush and freeze artefacts were not observed and tissue architecture was 
intact in all specimens. Small blood vessels and terminal bronchioles were observed in 
88% of specimens. All cryobiopsies caused nil or mild haemorrhage with the exception 
of only 1 episode of severe haemorrhage at 6 s freezing time. Pneumothoraces occurred 
at 2, 5 and 6 s freezing time and required chest tube insertion. The most significant 
haemorrhage and pneumothoraces occurred at 5 and 6 s. Our results suggest an initial 
freezing time of 3 s can provide the maximal biopsy size while minimising major 
complications. Conclusion: The optimal transbronchial cryobiopsy freezing time is 








Bronchoscopic transbronchial lung biopsy is a commonly used technique to obtain 
tissue specimens from the peripheral lung to evaluate diffuse parenchymal infiltrates and 
lung masses. Traditionally, transbronchial biopsies involve the use of flexible forceps to 
obtain specimens. However, there are several limitations of this technique including the 
small biopsy size, the biopsy only containing mucus or being very superficial, and the 
susceptibility to crush artefact. These hamper histopathological analysis and thereby limit 
diagnostic yield [1, 2]. 
Transbronchial cryobiopsy is a novel method that has the potential to increase the 
diagnostic yield of transbronchial lung biopsies. Through the cryoadhesive effect, large 
specimens that demonstrate unaltered and artefact-free morphology can be obtained [3--
7]. Transbronchial cryobiopsy is a promising technique because both biopsy size and 
quality contribute to diagnostic value [8]. Early studies suggest that transbronchial 
cryobiopsy has a higher diagnostic yield with similar safety profiles to transbronchial 
forceps biopsies in interstitial lung disease [4, 6, 7, 9--13], lung transplantation rejection 
[14, 15] and transbronchial malignancy [16]. 
As the uptake of transbronchial cryobiopsies increases, the optimum technique is still 
being investigated. Uncertainty remains regarding the correct cryoprobe freezing time for 
optimum transbronchial cryobiopsies. Recent in vivo and ex vivo studies have provided 
conflicting reports of the correlation between biopsy weight and freezing time [8, 17]. 
Cryoprobe freezing times for transbronchial cryobiopsies have ranged from 3 to 5 s [4, 6, 
9, 14, 15], yet to date there has been no research into freezing times and its effect on in 
vivo transbronchial cryobiopsies. The primary aim of this animal study was to examine the 
relationship between the freezing time of transbronchial cryobiopsies and biopsy size. 
Secondary aims were to evaluate the risk of complications associated with each freezing 
time and the histological quality of cryobiopsy samples. 
Methods 
The study was conducted at the University of New South Wales Biological 




and December 2014. The study was approved by the University of New South Wales 
Animal Care and Ethics Committee. 
Protocol 
The transbronchial lung cryobiopsies were obtained from two healthy, 90-kg adult 
Border Leicester Merino cross sheep. The animals were anaesthetised using an 
intramuscular injection of tiletamine-zolazepam and maintained with isoflurane. A 
tracheotomy was performed and transbronchial cryobiopsies were obtained using a 2.8-
mm channel flexible bronchoscope (BF-1TH180, EVIS EXERA II CLV-180, Olympus 
Corp., Tokyo, Japan) and a 1.9-mm flexible cryoprobe (Erbokryo CA, ERBE Tübingen, 
Germany). 
One trained operator (J.P.W.) performed the transbronchial cryobiopsies. The 
cryoprobe was advanced under fluoroscopic guidance towards the pleura until resistance 
was met where it was withdrawn approximately 10 mm. The probe was then cooled using 
compressed carbon dioxide to achieve specific freezing times. The cryoprobe activation 
time was increased incrementally for 1, 2, 3, 4, 5 or 6 s to achieve individual 
cryobiopsies. Between 6 and 11 cryobiopsies were performed for each freezing time. 
Following freezing, the bronchoscope and cryoprobe with attached biopsy were removed 
en bloc. The frozen specimen was thawed in normal saline and immediately fixed in 10% 
buffered formalin. The segmental bronchi were selected randomly in a distal to proximal 
fashion, while freezing times were selected in a non-randomised fashion due to the 
potential risk of haemorrhage with larger freezing durations. 
Complication rates of haemorrhage and pneumothorax were recorded. 
Pneumothorax was assessed using fluoroscopic screening (BV300 C-Arm, Philips, The 
Netherlands) following each biopsy. Haemorrhage was graded based on the intervention 
required to achieve haemostasis. Grade 0: no haemorrhage, grade 1: suctioning, topical 
cold saline or adrenaline, grade 2: topical tranexamic acid, bronchial blocker, and grade 
3: haemodynamic instability leading to cessation of the procedure. The sheep were not 
recovered from anaesthesia and were sacrificed with an overdose of pentobarbitone 
sodium to undergo autopsy and tissue harvest. 
Histology 
Biopsy samples were fixed in 10% buffered formalin, embedded in paraffin and cut 
into 5-μm sections for staining with haematoxylin and eosin. The samples were analysed 




performed under a light microscope (BX60 Microscope and DP71 Camera, Olympus 
Corp., Tokyo, Japan). Automated analysis of the total area of the biopsy specimens was 
measured with interactive circling of the biopsy using the computer program Image J 
(version 1.48, Maryland, USA) and expressed in mm2. Features of artefact (crush 
artefact, atelectasis and specimen fragmentation) were assessed manually, as well as 
the percentage of specimens containing terminal bronchioles, small arteries and alveolar 
tissue. 
Statistical Analysis 
All data were analyzed using statistical software (SPSS version 22 for Windows, 
IBM Corp., N.Y., USA). Data was analysed and expressed via descriptive statistics 
(means and standard deviations). A linear regression model was performed to determine 
the correlation between biopsy area and freezing time. A Kruskal-Wallis with Dunn’s post 
test was performed to compare cross-sectional areas of different freezing times. A p 
value <0.05 was considered statistically significant. Complications and histological 
specimen quality are described qualitatively. 
Results 
Correlation between Freezing and Biopsy Size 
Forty-nine transbronchial cryobiopsies were taken with the 1.9-mm cryoprobe. 
Nineteen and thirty cryobiopsies were taken in each sheep, respectively. The mean cross-
sectional area of the cryobiopsies ranged from 4.7 ± 2.1 to 15.7 ± 15.3 mm2 (table 1). A 
strong correlation between freezing time and cryobiopsy area was demonstrated (r = 
0.7387) (fig. 1). There was a significant positive correlation between increasing freezing 
time and cross-sectional area of transbronchial cryobiopsies (p = 0.028). This correlation 
was specifically demonstrated through the 5- and 6-second freezing times, as there was 
no statistically significant difference between cryobiopsy cross-sectional area at 1--4 s 
freezing times (fig. 2). 
Complications 
The majority of transbronchial cryobiopsies were associated with grade 0--1 
haemorrhage (98%) (table 2). There was only one grade 3 haemorrhage that occurred at 
6 s causing sacrifice of the animal. Three pneumothoraces occurred at 2, 5 and 6 s 




larger on fluoroscopy and caused greater oxygen desaturation (50--60%) than the 
pneumothorax occurring at 2 s. 
Histology 
Transbronchial cryobiopsy preserved the lung parenchyma with all biopsies containing 
lung tissue. Crush artefact was not seen and there was minimal tissue fragmentation and 
atelectasis. Tissue architecture was intact in the majority of specimens (fig. 3). Small 
blood vessels and terminal bronchioles were observed in 88% of all specimens, while 
alveolar tissue was identified in 92% of all specimens (table 3). 
Discussion 
This is the first study to examine the relationship between in vivo transbronchial 
cryobiopsy size and freezing time. We were able to demonstrate in sheep a significant 
positive correlation between 1.9-mm cryoprobe freezing times and transbronchial 
cryobiopsy cross-sectional area. There was no statistical difference in cryobiopsy cross-
sectional area between 1--4 s freezing time and serious complications occurred only at 5 
and 6 s. Based on practicality and safety, we recommend an initial freezing time of 3 s. 
Technically, a 3-second freezing time period is easily achievable, provides a large biopsy 
size whilst creating a safety threshold from complications. This has implications in guiding 
the optimal application of transbronchial cryobiopsies in human populations. 
Due to the novel nature of this study, comparison of freezing time and cryobiopsy area 
to previous literature is limited. In one in vitro study, non-perfused porcine lung 
demonstrated a strong positive correlation between biopsy weight, diameter of the probe 
and freezing time [17]. However, for endobronchial samples, one in vivo prospective 
animal study found only a moderate correlation between biopsy weight and specimen 
diameter and the freezing period [8]. This inconsistency may be explained by the different 
nature of structures located in central airways for endobronchial applications of the 
cryoprobe, when compared to peripheral lung parenchyma, which we sampled. It has 
been shown that cryosensitivity depends on microcirculation and water content of the 
tissue [17]. Areas with higher rates of collagen, cartilage or poorly vascularised tissue 
(such as the proximal bronchial wall) are less susceptible to the cryoadhesive effect [18]. 
In terms of biopsy size, a similar transbronchial cryobiopsy cross-sectional area has 




5 s freezing (17.1 ± 10.7 mm2) [4, 6, 9, 14]. The significant positive correlation between 
freezing time and cross-sectional cryobiopsy area can be explained by the concentric 
expansion of the frozen zone that radiates from the tip of the cryoprobe [2]. Theoretically, 
by increasing freezing times, a larger surface area and subsequently larger biopsies can 
be generated. 
This study demonstrated the variable cross-sectional area and a high degree of 
standard deviation with freezing times. This variability in cross-sectional area has also 
been evident in previous studies [6, 9]. Despite the use of fluoroscopic guidance, flexible 
bronchoscopy and standardised placement of the cryoprobe, the operator cannot 
consistently ensure the placement of the probe is perpendicular (optimal) to the mucosa of 
the segmental bronchus. There is natural variability in placement and lateral application of 
the cryoprobe was observed in multiple cases [8]. As the cryobiopsy area is highly 
dependent on the contact area between the cryoprobe and the tissue [17, 18], this may 
explain the considerable variability seen in cross-sectional area especially observed with 
increasing freezing time. 
Our study noted a high histological quality of transbronchial cryobiopsies. 
Cryobiopsies have demonstrated significantly larger size and alveolar sampling, lower 
evidence of artefact, preservation of tissue architecture and greater ability for 
immunohistochemical processing in comparison to transbronchial forceps biopsy [4, 6, 10-
-12, 14, 15]. These unique characteristics of transbronchial cryobiopsy have resulted in 
higher diagnostic yield in parenchymal pulmonary lesions [16] and identification of lung 
transplant rejection [14, 15] and support the utility of transbronchial biopsies in interstitial 
lung diseases, an area where bronchoscopic biopsies have traditionally been considered 
to have a low yield [4, 6, 10--12]. Freezing times that provide the largest artefact-free 
specimen will therefore likely maximise diagnostic yield. 
There have been very few studies evaluating the safety of transbronchial cryobiopsies 
when compared to forceps biopsy. One study found no difference in the safety profiles 
between transbronchial forceps and cryobiopsy in regards to pneumothorax, bleeding or 
the need for hospitalization in diffuse lung disease and lung transplant patients [13]. 
Haemorrhage and pneumothorax represent the most common complications and we 
found these complications were associated with freezing times of 5 and 6 s. Despite the 
increasing size of the cryobiopsies with freezing time, only one grade 3 haemorrhage 
occurred during sampling. Previous literature has suggested that procedural sedation and 




rate of significant haemorrhage may be due to the appearance of intra- and extracellular 
ice crystals causing temporary vasoconstriction [18]. In the 49 biopsies performed, only 3 
significant pneumothoraces occurred, all resolving with intercostal catheter insertion. 
However, there was difficulty drawing a definitive conclusion, as subsequent 
pneumothorax could not be assessed after intercostal catheter insertion. Nevertheless, 
both complications have been reported to occur at similar rates for both transbronchial 
cryobiopsy and forceps biopsy [4, 6, 14, 15]. 
The use of a large animal model and standardized operating protocol adds to the 
strength and reproducibility of the study. Our sheep model has direct applicability to 
human models. Sheep have airway structures and functions that closely resemble human 
lungs [20, 21]. Due to these similarities, sheep have been used to model human lung 
pathology such as emphysema, asthma and chronic bronchitis [20]. Therefore, 
extrapolation of results that support 3 s as the optimal initial freezing time in sheep is likely 
to be valid for human transbronchial cryobiopsies. It may guide future research protocols 
in human studies and its end use as a diagnostic tool in patients with different lung 
pathology. 
However, there remain particular limitations associated with our study. Despite the 
strength of airway and parenchymal similarities, care must be exercised in drawing 
conclusions from sheep models. Furthermore, a larger sample size over multiple sites 
may help further delineate differences between cross-sectional area and particular 
freezing times. This larger sample size may also potentially help explore the relationship 
between longer freezing times and the higher risk of complications. 
This research adds to the growing body of evidence regarding the safe application of 
transbronchial cryobiopsies. We recommend the initial use of 3 s freezing time and 
subsequent use of 4 s freezing time if adequate samples are not initially obtained. This 
timeframe maintains optimal biopsy size while minimising common complications. 
Acknowledgements 
The cryoprobe was donated by ERBE Germany. Olympus Australia provided the 






There are no conflicts of interest to declare. 
References 
1 Schumann C, Hetzel J, Babiak AJ, Merk T, Wibmer T, Moller P, Lepper PM, Hetzel 
M: Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J 
Thorac Cardiovasc Surg 2010;140:417--421. 
2 Hetzel J, Eberhardt R, Herth FJ, Petermann C, Reichle G, Freitag L, Dobbertin I, 
Franke KJ, Stanzel F, Beyer T, Moller P, Fritz P, Ott G, Schnabel PA, Kastendieck H, 
Lang W, Morresi-Hauf AT, Szyrach MN, Muche R, Shah PL, Babiak A, Hetzel M: 
Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. 
Eur Respir J 2012;39:685--690. 
3 Hetzel J, Hetzel M, Hasel C, Moeller P, Babiak A: Old meets modern: the use of 
traditional cryoprobes in the age of molecular biology. Respiration 2008;76:193--197. 
4 Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P, Balli T, Hetzel M: Transbronchial 
cryobiopsy: a new tool for lung biopsies. Respiration 2009;78:203--208. 
5 Aktas Z, Gunay E, Hoca NT, Yilmaz A, Demirag F, Gunay S, Sipit T, Kurt EB: 
Endobronchial cryobiopsy or forceps biopsy for lung cancer diagnosis. Ann Thorac 
Med 2010;5:242--246. 
6 Pajares V, Puzo C, Castillo D, Lerma E, Montero MA, Ramos-Barbón D, Amor-
Carro O, Gil de Bernabé A, Franquet T, Plaza V, Hetzel J, Sanchis J, Torrego A: 
Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized 
trial. Respirology 2014;19:900--906. 
7 Torrego A, Pajares V: Transbronchial cryobiopsy in diffuse lung disease. Curr 
Respir Care Rep 2014;3:7--12. 
8 Franke KJ, Theegarten D, Hann von Weyhern C, Nilius G, Brueckner C, Hetzel J, 
Hetzel M, Ruhle KH, Enderle MD, Szyrach MN: Prospective controlled animal study on 
biopsy sampling with new flexible cryoprobes versus forceps: evaluation of biopsy size, 
histological quality and bleeding risk. Respiration 2010;80:127--132. 
9 Griff S, Ammenwerth W, Schonfeld N, Bauer TT, Mairinger T, Blum TG, Kollmeier J, 





10 Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, Carretta E, 
Tantalocco P, Piciucchi S, Ravaglia C, Gurioli C, Romagnoli M, Gurioli C, Chilosi M, 
Poletti V: Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung 
diseases. PLoS One 2014;9:e86716. 
11 Kropski J, Pritchett J, Mason W, Sivarajan L, Gleaves L, Johnson J, Lancaster L, 
Lawson W, Blackwell T, Steele M, Loyd J, Rickman O: Bronchoscopic cryobiopsy for 
the diagnosis of diffuse parenchymal lung disease. PLoS One 2013;8:e78674. 
12 Fruchter O, Fridel L, El Raouf BA, Abdel-Rahman N, Rosengarten D, Kramer MR: 
Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy. 
Respirology 2014;19:683--688. 
13 Gershman E, Fruchter O, Benjamin F, Nader AR, Rosengarten D, Rusanov V, 
Fridel L, Kramer MR: Safety of cryo-transbronchial biopsy in diffuse lung diseases: 
analysis of three hundred cases. Respiration 2015;90:40--46. 
14 Fruchter O, Fridel L, Rosengarten D, Raviv Y, Rosanov V, Kramer MR: 
Transbronchial cryo-biopsy in lung transplantation patients: first report. Respirology 
2013;18:669--673. 
15 Yarmus LDOF, Akulian JMD, Gilbert CDO, Illei PMD, Shah PMD, Merlo CMD, 
Orens JMDF, Feller-Kopman DMDF: Cryoprobe transbronchial lung biopsy in patients 
after lung transplantation: a pilot safety study. Chest 2013;143:621--626. 
16 Schuhmann M, Bostanci K, Bugalho A, Warth A, Schnabel PA, Herth FJ, Eberhardt 
R: Endobronchial ultrasound-guided cryobiopsies in peripheral pulmonary lesions: a 
feasibility study. Eur Respir J 2014;43:233--239. 
17 Franke KJ, Szyrach M, Nilius G, Hetzel J, Hetzel M, Ruehle KH, Enderle MD: 
Experimental study on biopsy sampling using new flexible cryoprobes: influence of 
activation time, probe size, tissue consistency, and contact pressure of the probe on 
the size of the biopsy specimen. Lung 2009;187:253--259. 
18 Vergnon JM, Huber RM, Moghissi K: Place of cryotherapy, brachytherapy and 
photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J 
2006;28:200--218. 
19 Poletti V, Hetzel J: Transbronchial cryobiopsy in diffuse parenchymal lung disease: 
need for procedural standardization. Respiration 2015;90:275--278. 
20 Meeusen EN, Snibson KJ, Hirst SJ, Bischof RJ: Sheep as a model species for the 
study and treatment of human asthma and other respiratory diseases. Drug Discov 




21 Scheerlinck J-P Y, Snibson KJ, Bowles VM, Sutton P: Biomedical applications of 
sheep models: from asthma to vaccines. Trends Biotechnol 2008;26:259--266. 
Appendix after References (Editorial Comments) 
 
Legend(s) 
Fig. 1. Correlation between freezing time and transbronchial cryobiopsy cross-sectional 
area. 
Fig. 2. Comparison of cross-sectional area of different freezing times. 
Fig. 3. Preserved tissue architecture of transbronchial lung cryobiopsy. Five-micrometer 
section stained in haematoxylin and eosin. Preserved tissue architecture without 
crush artefact. Normal alveoli with minimal atelectasis (dotted arrow). Terminal 







Table 1. Transbronchial cryobiopsy cross-sectional area 
 
 
 Cryoprobe freezing time, s 
   1 2 3 4 5 6 
       
       
Number of biopsies 8 8 11 9 7 6 
Cross-sectional area, mm2 5.5 4.7 6.5 7.1 9.0 15.7 
Standard deviation 2.3 2.1 2.2 2.8 5.7 15.3 
       





Table 2. Complications associated with freezing times 
       
       
Complications Freezing time, s 
   1 2 3 4 5 6 
       
       
Haemorrhage       
Grade 0 4 (50) 3 (38) 2 (18) 4 (44) 2 (29) 3 (50) 
Grade 1 4 (50) 5 (62) 9 (82) 5 (56) 5 (71) 2 (33) 
Grade 2 0 0 0 0 0 0 
Grade 3 0 0 0 0 0 1 (17) 
Pneumothorax Nil 1 Nil Nil 1 1 
       
       







Table 3. Histological quality of cryobiopsy specimen 
 
 
Histology Freezing time, s 
   1 2 3 4 5 6 
       
       
Number of biopsies 8 8 11 9 7 6 
Small arterioles 7 (88) 7 (88) 09 (82) 8 (89) 6 (86) 6 (100) 
Terminal bronchioles 7 (88) 7 (88) 09 (82) 8 (89) 6 (86) 6 (100) 
Alveolar tissue 7 (88) 7 (88) 10 (91) 8 (89) 7 (100) 6 (100) 
       
       
Figures in parentheses are percentages. 
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